Wire Stories
-
546Fabrinet to Announce Third Quarter 2021 Financial Results on May 3, 2021
BANGKOK, Thailand–(BUSINESS WIRE)–#EarningsDate–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original...
-
592
BevCanna’s Naturo Group Signs Exclusive Distribution Agreement for TRACE in Japan and the Philippines
Market entry will address pent-up demand in the Japanese & Philippine markets for TRACE proprietary plant-based mineral formulation and wellness-focused products VANCOUVER,...
-
638
Druva Secures $147 Million Investment to Extend Market Leadership
New Funding to Fuel Continued Innovation, Scale, and Expand Routes to Market for Druva Cloud Platform SUNNYVALE, Calif.–(BUSINESS WIRE)–Druva Inc., the leader...
-
555
FAX Capital Provides Date for Q1 2021 Results
NOT FOR DISSEMINATION IN THE UNITED STATES OR DISTRIBUTION TO U.S. NEWS WIRE SERVICES TORONTO, April 19, 2021 (GLOBE NEWSWIRE) — FAX...
-
559
Gilat Awarded Over $20 Million in Orders for Support of Low Earth Orbit Constellation
PETAH TIKVA, Israel, April 19, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite...
-
668
PTT Invests in Lotus Pharmaceutical’s Strategic Partnership in South East Asia
The transaction creates a very strong platform to expand market access in the ASEAN region. Both parties are committed to further collaboration...
-
561
Westwater Resources to Present at the Planet MicroCap Showcase: VIRTUAL on Thursday, April 22, 2021
CENTENNIAL, Colo.–(BUSINESS WIRE)–$WWR #batterygraphite—Westwater Resources, Inc. (NYSE American: WWR), an energy materials development company, today announced it will be presenting at the...
-
593
Humanigen Reports Positive Data With Lenzilumab in the ZUMA-19 CAR-T Phase 1b Study in DLBCL and Plans to Initiate a Potential Registrational Study
At the recommended Phase 2 dose, lenzilumab in combination with CAR-T, demonstrated a 100% objective response rate (ORR) and no severe cytokine...
-
647
Transferred from UAE, 2.5 year old Afghan Girl Makes Miraculous Recovery by a Bone Marrow Transplant at Aster MIMS Hospital, India
LAHORE, Pakistan–(BUSINESS WIRE)–#Afghangirl–Kulsum, a 2.5 year old native of Afghanistan and Pakistani passport holder, miraculously recovered after a rare bone marrow transplant...
-
646
Roxgold Announces Robust S�gu�la Feasibility Study with After-Tax NPV of US$380 Million and 49% IRR
TORONTO–(BUSINESS WIRE)–Roxgold Inc. (�Roxgold� or the �Company�) (TSX: ROXG) (OTCQX: ROGFF) is pleased to announce the results of the Feasibility Study (the...
